Mar 18, 2018
Hillary Theakston, Executive Director, Clearity Foundation spoke at the recent Future of Genomic Medicine conference produced by the Scripps Translational Science Institute and The Scripps Research Institute. The Clearity Foundation is a great example of precision medicine in action as the Foundation produces a Tumor Blueprint for those with ovarian cancer who enroll in their program. This tumor profile can help patients and their doctors identify appropriate clinical trials, the most likely to succeed treatment, and enhance the growing genomic database of ovarian cancer mutations and drugs most likely to be effective for each individual.
@clearityfnd